Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial

Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial

Objective: To assess the safety and efficacy of convalescent plasma (CP) transfusion in elderly people with moderate to severe coronavirus disease 2019 (COVID-19) living in a long-term care facility (LTCF). Patients and Methods: Twenty-two consecutive elderly patients with COVID-19 infection living...

Full description

Bibliographic Details
Main Authors: Massimo Franchini, MD, Claudia Glingani, BSc, Mario Morandi, PhD, Giovanni Corghi, PhD, Sara Cerzosimo, PhD, Gloria Beduzzi, PhD, Andrea Storti, PhD, Vincenza Di Stasi, PhD, Giulia Rastrelli, PhD, Linda Vignozzi, PhD, Carlo Mengoli, PhD, Martina Garuti, PhD, Massimiliano Beccaria, PhD, Francesco Inglese, PhD, Beatrice Caruso, PhD, Roberto Antonio Petilino, PhD, Massimo Amato, PhD, Michele Nicchio, PhD, Mauro Pagani, PhD, Angela Bellani, PhD, Gianpaolo Castelli, PhD, Salvatore Casari, PhD, Giuseppe De Donno, PhD
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454821000291

Internet

http://www.sciencedirect.com/science/article/pii/S2542454821000291

Similar Items